Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2010 2
2011 6
2012 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT. Chang TC, et al. Mol Cell. 2007 Jun 8;26(5):745-52. doi: 10.1016/j.molcel.2007.05.010. Epub 2007 May 31. Mol Cell. 2007. PMID: 17540599 Free PMC article.
Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
Zhang XJ, Ye H, Zeng CW, He B, Zhang H, Chen YQ. Zhang XJ, et al. J Hematol Oncol. 2010 Nov 24;3:46. doi: 10.1186/1756-8722-3-46. J Hematol Oncol. 2010. PMID: 21106054 Free PMC article.
MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer.
Ohuchida K, Mizumoto K, Kayashima T, Fujita H, Moriyama T, Ohtsuka T, Ueda J, Nagai E, Hashizume M, Tanaka M. Ohuchida K, et al. Ann Surg Oncol. 2011 Aug;18(8):2381-7. doi: 10.1245/s10434-011-1602-x. Epub 2011 Feb 23. Ann Surg Oncol. 2011. PMID: 21347785 Free PMC article.
Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer.
LaConti JJ, Shivapurkar N, Preet A, Deslattes Mays A, Peran I, Kim SE, Marshall JL, Riegel AT, Wellstein A. LaConti JJ, et al. PLoS One. 2011;6(6):e20687. doi: 10.1371/journal.pone.0020687. Epub 2011 Jun 27. PLoS One. 2011. PMID: 21738581 Free PMC article.
Differentially expressed microRNAs in pancreatic cancer stem cells.
Jung DE, Wen J, Oh T, Song SY. Jung DE, et al. Pancreas. 2011 Nov;40(8):1180-7. doi: 10.1097/MPA.0b013e318221b33e. Pancreas. 2011. PMID: 21785383
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, Xiang D, Desano JT, Bommer GT, Fan D, Fearon ER, Lawrence TS, Xu L. Ji Q, et al. PLoS One. 2009 Aug 28;4(8):e6816. doi: 10.1371/journal.pone.0006816. PLoS One. 2009. PMID: 19714243 Free PMC article.
MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma.
Jamieson NB, Morran DC, Morton JP, Ali A, Dickson EJ, Carter CR, Sansom OJ, Evans TR, McKay CJ, Oien KA. Jamieson NB, et al. Clin Cancer Res. 2012 Jan 15;18(2):534-45. doi: 10.1158/1078-0432.CCR-11-0679. Epub 2011 Nov 23. Clin Cancer Res. 2012. PMID: 22114136 Free article.
Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas.
Vogt M, Munding J, Grüner M, Liffers ST, Verdoodt B, Hauk J, Steinstraesser L, Tannapfel A, Hermeking H. Vogt M, et al. Virchows Arch. 2011 Mar;458(3):313-22. doi: 10.1007/s00428-010-1030-5. Epub 2011 Jan 12. Virchows Arch. 2011. PMID: 21225432
Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer.
Hwang JH, Voortman J, Giovannetti E, Steinberg SM, Leon LG, Kim YT, Funel N, Park JK, Kim MA, Kang GH, Kim SW, Del Chiaro M, Peters GJ, Giaccone G. Hwang JH, et al. PLoS One. 2010 May 14;5(5):e10630. doi: 10.1371/journal.pone.0010630. PLoS One. 2010. PMID: 20498843 Free PMC article.
Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
Nalls D, Tang SN, Rodova M, Srivastava RK, Shankar S. Nalls D, et al. PLoS One. 2011;6(8):e24099. doi: 10.1371/journal.pone.0024099. Epub 2011 Aug 31. PLoS One. 2011. PMID: 21909380 Free PMC article.
Feedback